Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-22 Sale | 2020-09-24 4:21 pm | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 720 | $18.12 | $13,046 | 52,012 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:43 pm | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 779 | $11.75 | $9,153 | 52,732 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-26 Option Award | 2024-03-13 5:52 pm | 2025-02-26 2034-02-25 | IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | 65,203 | $0 | 65,203 (Direct) | View |
Ownership | 2024-03-13 5:52 pm | N/A N/A | IONIS PHARMACEUTICALS INC | IONS | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | 0 | $0 | 1,989 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2028-01-01 | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 14,000 | $0.77 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 176,125 | $5.94 | 0 (Direct) | View |
| 2020-10-12 Equity Swap | 2020-10-13 3:59 pm | N/A N/A | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 52,012 | $18.15 | 0 (Direct) | View |
| 2020-10-12 Disposition | 2020-10-13 3:59 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 34,200 | $5.39 | 0 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:34 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer | 51,000 | $0 | 87,711 (Direct) | View |